August 12, 2021

Third COVID-19 vaccine dose effective and safe for transplant recipients: study

Researchers say $2.1 million will back efforts at determining vaccine effectiveness among people with blood cancers including leukemia, lymphoma and myeloma. They expect to recruit 1,400 people from more than a dozen hospitals

Click here to read the full article.